StonvexLoading…
StonvexStonvexStonvexCore line items from INSM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $606.42M | $363.71M | $305.21M | $245.36M |
Operating Income | $-1.25B | $-878.25M | $-709.63M | $-457.32M |
Net Income | $-1.28B | $-913.77M | $-749.57M | $-481.53M |
EPS (Diluted) | $-6.42 | $-5.57 | $-5.34 | $-3.91 |
Total Assets | $2.26B | $2.03B | $1.33B | $1.66B |
Total Liabilities | $1.53B | $1.74B | $1.66B | $1.57B |
Cash & Equivalents | $510.44M | $555.03M | $482.37M | $1.07B |
Free Cash Flow OCF − CapEx | $-967.58M | $-705.80M | $-549.53M | $-410.32M |
Shares Outstanding | 214.26M | 179.38M | 147.98M | 135.65M |